BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 22128892)

  • 1. Targeting hypoxic tumour cells to overcome metastasis.
    Bennewith KL; Dedhar S
    BMC Cancer; 2011 Nov; 11():504. PubMed ID: 22128892
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypoxia-induced treatment failure in advanced squamous cell carcinoma of the uterine cervix is primarily due to hypoxia-induced radiation resistance rather than hypoxia-induced metastasis.
    Rofstad EK; Sundfør K; Lyng H; Tropé CG
    Br J Cancer; 2000 Aug; 83(3):354-9. PubMed ID: 10917551
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Microenvironment-induced cancer metastasis.
    Rofstad EK
    Int J Radiat Biol; 2000 May; 76(5):589-605. PubMed ID: 10866281
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HIF expression and the role of hypoxic microenvironments within primary tumours as protective sites driving cancer stem cell renewal and metastatic progression.
    Philip B; Ito K; Moreno-Sánchez R; Ralph SJ
    Carcinogenesis; 2013 Aug; 34(8):1699-707. PubMed ID: 23740838
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The hypoxic tumour microenvironment and metastatic progression.
    Subarsky P; Hill RP
    Clin Exp Metastasis; 2003; 20(3):237-50. PubMed ID: 12741682
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting radiation-resistant hypoxic tumour cells through ATR inhibition.
    Pires IM; Olcina MM; Anbalagan S; Pollard JR; Reaper PM; Charlton PA; McKenna WG; Hammond EM
    Br J Cancer; 2012 Jul; 107(2):291-9. PubMed ID: 22713662
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypoxic control of metastasis.
    Rankin EB; Giaccia AJ
    Science; 2016 Apr; 352(6282):175-80. PubMed ID: 27124451
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of hypoxic signalling in metastasis: towards translating knowledge of basic biology into novel anti-tumour strategies.
    Araos J; Sleeman JP; Garvalov BK
    Clin Exp Metastasis; 2018 Oct; 35(7):563-599. PubMed ID: 30171389
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of nicotinamide on human tumour hypoxic fraction measured using the comet assay.
    McLaren DB; Pickles T; Thomson T; Olive PL
    Radiother Oncol; 1997 Nov; 45(2):175-82. PubMed ID: 9424009
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lysyl oxidase is essential for hypoxia-induced metastasis.
    Erler JT; Bennewith KL; Nicolau M; Dornhöfer N; Kong C; Le QT; Chi JT; Jeffrey SS; Giaccia AJ
    Nature; 2006 Apr; 440(7088):1222-6. PubMed ID: 16642001
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison between the comet assay and the oxygen microelectrode for measurement of tumor hypoxia.
    Aquino-Parsons C; Luo C; Vikse CM; Olive PL
    Radiother Oncol; 1999 May; 51(2):179-85. PubMed ID: 10435811
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of hypoxic preconditioning on neuroblastoma tumour oxygenation and metabolic signature in a chick embryo model.
    Al-Mutawa YK; Herrmann A; Corbishley C; Losty PD; Phelan M; Sée V
    Biosci Rep; 2018 Aug; 38(4):. PubMed ID: 30026261
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radiobiological and immunohistochemical assessment of hypoxia in human melanoma xenografts: acute and chronic hypoxia in individual tumours.
    Rofstad EK; Måseide K
    Int J Radiat Biol; 1999 Nov; 75(11):1377-93. PubMed ID: 10597912
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypoxic modification of radiotherapy in squamous cell carcinoma of the head and neck--a systematic review and meta-analysis.
    Overgaard J
    Radiother Oncol; 2011 Jul; 100(1):22-32. PubMed ID: 21511351
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting DNA topoisomerase IIα (TOP2A) in the hypoxic tumour microenvironment using unidirectional hypoxia-activated prodrugs (uHAPs).
    Smith PJ; McKeown SR; Patterson LH
    IUBMB Life; 2023 Jan; 75(1):40-54. PubMed ID: 35499745
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LET-painting increases tumour control probability in hypoxic tumours.
    Bassler N; Toftegaard J; Lühr A; Sørensen BS; Scifoni E; Krämer M; Jäkel O; Mortensen LS; Overgaard J; Petersen JB
    Acta Oncol; 2014 Jan; 53(1):25-32. PubMed ID: 24020629
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phenotypic heterogeneity of disseminated tumour cells is preset by primary tumour hypoxic microenvironments.
    Fluegen G; Avivar-Valderas A; Wang Y; Padgen MR; Williams JK; Nobre AR; Calvo V; Cheung JF; Bravo-Cordero JJ; Entenberg D; Castracane J; Verkhusha V; Keely PJ; Condeelis J; Aguirre-Ghiso JA
    Nat Cell Biol; 2017 Feb; 19(2):120-132. PubMed ID: 28114271
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic Targeting of the Tumour Microenvironment in Metastatic Colorectal Cancer.
    Dmello RS; To SQ; Chand AL
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33669775
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The tumor bed effect: increased metastatic dissemination from hypoxia-induced up-regulation of metastasis-promoting gene products.
    Rofstad EK; Mathiesen B; Henriksen K; Kindem K; Galappathi K
    Cancer Res; 2005 Mar; 65(6):2387-96. PubMed ID: 15781654
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The hypoxic tumour microenvironment, patient selection and hypoxia-modifying treatments.
    Hoogsteen IJ; Marres HA; van der Kogel AJ; Kaanders JH
    Clin Oncol (R Coll Radiol); 2007 Aug; 19(6):385-96. PubMed ID: 17433637
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.